Telmisartan does not improve six-minute walk distance in peripheral artery disease
For patients with lower-extremity peripheral artery disease (PAD), telmisartan does not improve six-minute walk distance compared with placebo at six-month follow-up, according to a study published in the Oct. 4 issue of ...
Oct 7, 2022
0
8